Your browser doesn't support javascript.
loading
Tirap controls Mycobacterium tuberculosis phagosomal acidification.
Belhaouane, Imène; Pochet, Amine; Chatagnon, Jonathan; Hoffmann, Eik; Queval, Christophe J; Deboosère, Nathalie; Boidin-Wichlacz, Céline; Majlessi, Laleh; Sencio, Valentin; Heumel, Séverine; Vandeputte, Alexandre; Werkmeister, Elisabeth; Fievez, Laurence; Bureau, Fabrice; Rouillé, Yves; Trottein, François; Chamaillard, Mathias; Brodin, Priscille; Machelart, Arnaud.
Afiliación
  • Belhaouane I; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
  • Pochet A; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
  • Chatagnon J; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
  • Hoffmann E; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
  • Queval CJ; High Throughput Screening Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Deboosère N; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
  • Boidin-Wichlacz C; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
  • Majlessi L; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université Paris Cité, Paris, France.
  • Sencio V; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
  • Heumel S; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
  • Vandeputte A; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
  • Werkmeister E; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
  • Fievez L; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UMS 2014-PLBS, Lille, France.
  • Bureau F; Laboratory of Cellular and Molecular Immunology, GIGA-Research, Liège, Belgium.
  • Rouillé Y; Laboratory of Cellular and Molecular Immunology, GIGA-Research, Liège, Belgium.
  • Trottein F; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
  • Chamaillard M; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
  • Brodin P; Laboratory of Cell Physiology, INSERM U1003, University of Lille, Lille, France.
  • Machelart A; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
PLoS Pathog ; 19(3): e1011192, 2023 03.
Article en En | MEDLINE | ID: mdl-36888688

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: PLoS Pathog Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: PLoS Pathog Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos